ESC 365 - Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

ESC Premium Access

Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

Session: Atrial fibrillation, stroke and cardiovascular risk

Topic: Biostatistics

Speaker: Mrs R. Hamershock (Boston, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mrs Rose Hamershock

Brigham and Women's Hospital, Boston (United States of America)

0 follower

6 more presentations in this session

Safety and effectiveness of dabigatran relative to warfarin in routine care: final results from a long-term monitoring program

Speaker: Doctor K. Zint (Ingelheim, DE)

Use of machine learning to determine stroke severity of patients diagnosed with stroke in claims data

Speaker: Doctor E. Kogan (Raritan, US)

National prescribing and adverse event rates of patients at risk of stroke with non-valvular AF from CPRD linked database: does 'big data' reflect clinical trials and identify areas for improvement?

Speaker: Doctor V. Mehta (London, GB)

Comparison of long DAPT versus short DAPT in Japanese PCI patients based on healthcare information database

Speaker: Doctor H. Yokoi (Fukuoka, JP)

Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations

Speaker: Doctor R. Rosenson (New York, US)

Access the full session

Atrial fibrillation, stroke and cardiovascular risk

Speakers: Mrs R. Hamershock, Doctor K. Zint, Doctor E. Kogan, Doctor V. Mehta, Doctor H. Yokoi...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources